DRUG STUDY

NURSING
NAME OF DRUG MECHANISM OF SIDE EFFECTS / CONSIDERATIONS
GENERAL ACTION ACTION INDICATIONS CONTRAINDICATIONS ADVERSE EFFECTS
Vitamins and minerals An enzyme that Used for Vit B Hypersensitivity to  Peripheral Before:
VITAMIN B stimulates metabolic complex deficiencies, Vitamin B12 or cobalt vascular 1. Right patient
COMPLEX function and is neuritis, polyneuritis thrombosis 2. Right medication
needed for cell peripheral, and  Heart failure 3. Right dose
Dose: 1 tablet replication, myalgia.  Pulmonary edema 4. Right route
Route: po hematopoiesis, and  Itching 5. Right time
Frequency: BID nucleoprotein and 6. Obtain a sensitivity
 Urticaria
myelin synthesis. test history before
administration
7. Determine
reticulocyte count,
hematocrit, Vit
B12, iron, folate
levels before
beginning therapy.

During:
1. Don’t give large
doses routinely
because drug is
lost through
excretion.
2. Avoid I.V.
administration
because faster
systemic
elimination will
reduce
effectiveness of
vitamin.

After:
1. Right
documentation
2. Protect from light.
Don’t refrigerate or
freeze.
 NURSING
NAME OF DRUG MECHANISM OF SIDE EFFECTS / CONSIDERATIONS
GENERAL ACTION ACTION INDICATIONS CONTRAINDICATIONS ADVERSE EFFECTS
Therapeutic Binds to calcium Used to treat Hypersensitivity to  Dizziness Before:
PREGABALIN Class: Anticonvulsant channel sites in CNS neuropathic pain drug or its  Drowsiness 1. Review history of
tissue, inhibiting conditions and components.  Ataxia seizure disorder
Dose: 75mg Pharmacological excitatory fibromyalgia.  Peripheral edema (type, onset,
Route: po Class: CNS drugs neurotransmitter Weight gain intensity,
Frequency: BID release. Exerts frequency,
 Blurred
antinociceptive,  Vision duration, LOC).
anticonvulsant activity. 2. Assess onset, type,
 Diplopia
location, and
 Difficulty with
duration of pain.
concentration,
attention, During:
cognition 1. Assess for seizure
 Tremor activity.
 Dry mouth, 2. Assess for clinical
Headache improvement;
 Constipation record onset of
 Asthenia relief of pain.
 Abnormal gait 3. Assess for
 Confusion evidence of
 Incoordination peripheral edema
 Twitching behind medial
 Flatulence malleolus (usually
 Vomiting first area of
 Edema edema).
 Myopathy 4. Provide safety
measures as
needed. Question
for changes in
visual acuity.

After:
1. Do not abruptly
stop taking drug;
seizure frequency
may be increased.
2. Avoid tasks that
require alertness,
 motor skills until
response to drug
is established.
3. Avoid alcohol.
4. Carry identification
card, bracelet to
note seizure
disorder,
anticonvulsant
therapy.

NURSING
NAME OF DRUG MECHANISM OF SIDE EFFECTS / CONSIDERATIONS
GENERAL ACTION ACTION INDICATIONS CONTRAINDICATIONS ADVERSE EFFECTS
Therapeutic Inhibits synthesis of Skin infections due  Avoid vaginal  Pruritus Before:
MICONAZOLE Class: Antifungal ergosterol (vital to dermatophytes or preparations during  Burning 1. Avoid occlusive
CREAM component of fungal yeasts and other first trimester of  Stinging dressings.
Pharmacological cell formation), fungi. pregnancy (unless  Erythema 2. Apply only small
Route: Topical Class: Imidazole damaging fungal cell essential to  Urticaria amount to cover
Frequency: BID derivative membrane. Acts very patient’s welfare). area completely.
rapidly on pruritus,  Contraindicated in
which frequently individuals with a During:
accompanies known 1. Assess for burning,
dermatophyte and hypersensitivity to pruritus, irritation.
yeast infections. miconazole,
After:
another ingredient
1. Rub well into
of the formulation,
affected areas.
or other imidazole
2. Avoid getting in
derivatives.
eyes.
 Sensitivity to other
3. Keep areas clean,
antifungals
dry; wear light
(clotrimazole,
clothing for
ketoconazole)
ventilation.
4. Separate personal
items in contact
with affected areas.
 NURSING
NAME OF DRUG MECHANISM OF SIDE EFFECTS / CONSIDERATIONS
GENERAL ACTION ACTION INDICATIONS CONTRAINDICATIONS ADVERSE EFFECTS
Therapeutic Inhibits bacterial For treatment of Hypersensitivity to  Pain Before:
MUPIROCIN Class: Antibacterial protein synthesis by impetigo and drug or its  Burning 1. Assess skin for
(Topical) reversibly and secondary skin components.  Stinging type, extent of
Route: Topical specifically binding to infections, leading to  Pruritus. lesions.
Frequency: BID Pharmacological bacterial isoleucyl traumatic skin  Rash
Class: Antibiotics transfer-RNA lesions, due to During:
 Nausea
synthetase. Staphylococcus 1. Monitor healing of
 Dry skin
aureus and skin lesions.
 Contact dermatitis 2. In event of skin
Streptococcus
pyogenes. reaction, stop
applications,
cleanse area
gently, notify
physician.
3. For external use
only.
4. Avoid contact with
eyes.

After:
1. Explain
precautions to
avoid spread of
infection; teach
how to apply
medication.
2. Report skin
reactions, irritation.
3. Report if no
improvement is
noted in 3–5 days.